Cargando…

Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway

Tubeimoside-1 (TBMS1), a triterpenoid saponin isolated from the tuber of Bolbostemma paniculatum (Maxim) Franquet, serves an universal suppressive role in multiple cancer types, including lung cancer. However, the mechanism involved in non-small cell lung cancer (NSCLC) cells by which TBMS1 elicits...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Hanbing, Bi, Hongxia, Sun, Xingyuan, Dong, Haiying, Jiang, Yunfei, Mu, Haijun, Liu, Guohua, Kong, Weili, Gao, Ruizhi, Su, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802206/ https://www.ncbi.nlm.nih.gov/pubmed/29363720 http://dx.doi.org/10.3892/mmr.2018.8459

Ejemplares similares

Tubeimoside-1 inhibits the proliferation and metastasis by promoting miR-126-5p expression in non-small cell lung cancer cells
por: Shi, Hanbing, et al.
Publicado: (2018)

Inhibitory effect and mechanism of hirsuteine on NCI‑H1299 lung cancer cell lines
por: Yun, Xuelin, et al.
Publicado: (2023)

Transcriptome Analysis of the Inhibitory Effects of 20(S)-Protopanaxadiol on NCI-H1299 Non-Small Cell Lung Cancer Cells
por: Cong, Zhongyi, et al.
Publicado: (2023)

Targeting VEGF/VEGFR to Modulate Antitumor Immunity
por: Yang, Ju, et al.
Publicado: (2018)

Tubeimoside 1 Acts as a Chemotherapeutic Synergist via Stimulating Macropinocytosis
por: Gong, Xianling, et al.
Publicado: (2018)

Corrigendum: Tubeimoside 1 Acts as a Chemotherapeutic Synergist via Stimulating Macropinocytosis
por: Gong, Xianling, et al.
Publicado: (2021)

MicroRNAs-1299, -126-3p and -30e-3p as Potential Diagnostic Biomarkers for Prediabetes
por: Weale, Cecil J., et al.
Publicado: (2021)

人非小细胞肺癌NCI-H1299细胞特异性结合肽的筛选及鉴定
Publicado: (2020)

Adjuvant activity of tubeimosides by mediating the local immune microenvironment
por: Han, Ziyi, et al.
Publicado: (2023)

SAIF plays anti-angiogenesis via blocking VEGF-VEGFR2-ERK signal in tumor treatment
por: Xie, Junye, et al.
Publicado: (2023)

VEGF-VEGFR Signals in Health and Disease
por: Shibuya, Masabumi
Publicado: (2014)

Tubeimoside-1: A review of its antitumor effects, pharmacokinetics, toxicity, and targeting preparations
por: Wang, Chang-Lin, et al.
Publicado: (2022)

Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model
por: Gu, Yuan, et al.
Publicado: (2015)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer
por: Dziobek, Konrad, et al.
Publicado: (2019)

Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma
por: Nascimento, Catarina, et al.
Publicado: (2021)

Phosphorylation of Akt and ERK1/2 Is Required for VEGF-A/VEGFR2-Induced Proliferation and Migration of Lymphatic Endothelium
por: Dellinger, Michael T., et al.
Publicado: (2011)

Low Temperature Plasma Suppresses Lung Cancer Cells Growth via VEGF/VEGFR2/RAS/ERK Axis
por: Zhou, Yuanyuan, et al.
Publicado: (2022)

Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3
por: Zhang, Wei, et al.
Publicado: (2023)

Magnoflorine—Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer Cells
por: Okon, Estera, et al.
Publicado: (2020)

环状RNA CircHIPK3通过miR-379调控IGF1表达促进非小细胞肺癌细胞系NCI-H1299与NCI-H2170的细胞增殖
Publicado: (2017)

VEGF-dependent tumor angiogenesis requires the inverse and reciprocal regulation of VEGFR1 and VEGFR2
por: Zhang, Zhaocheng, et al.
Publicado: (2009)

Genetic variations in VEGF and VEGFR2 and glioblastoma outcome
por: Sjöström, S., et al.
Publicado: (2010)

Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
por: Yang, Gui-Li, et al.
Publicado: (2018)

The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy
por: Mabeta, Peace, et al.
Publicado: (2022)

Structure-Based Design of Peptides Targeting VEGF/VEGFRs
por: Di Stasi, Rossella, et al.
Publicado: (2023)

Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin
por: Ma, Rundi, et al.
Publicado: (2007)

Pharmacokinetics and Bioavailability Study of Tubeimoside I in ICR Mice by UPLC-MS/MS
por: Chen, Lianguo, et al.
Publicado: (2018)

Tubeimoside I Antagonizes Yoda1-Evoked Piezo1 Channel Activation
por: Liu, Silin, et al.
Publicado: (2020)

Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells
por: Garvin, S, et al.
Publicado: (2005)

ERK signaling is required for VEGF-A/VEGFR2-induced differentiation of porcine adipose-derived mesenchymal stem cells into endothelial cells
por: Almalki, Sami G., et al.
Publicado: (2017)

Siamese crocodile bile induces apoptosis in NCI-H1299 human non-small cell lung cancer cells via a mitochondria-mediated intrinsic pathway and inhibits tumorigenesis
por: Tian, Ling, et al.
Publicado: (2017)

Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A
por: Chen, Hongxia, et al.
Publicado: (2014)

The role of the VEGF-C/VEGFR-3 axis in cancer progression
por: Su, J-L, et al.
Publicado: (2007)

The Role of the VEGF-C/VEGFRs Axis in Tumor Progression and Therapy
por: Chen, Jui-Chieh, et al.
Publicado: (2012)

Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?
por: Li, Yu-Ling, et al.
Publicado: (2016)

VEGF-A splice variants bind VEGFRs with differential affinities
por: Mamer, Spencer B., et al.
Publicado: (2020)

Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
por: Liu, Guihong, et al.
Publicado: (2021)

Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
por: Bando, H, et al.
Publicado: (2005)

Profiling of VEGFs and VEGFRs as Prognostic Factors in Soft Tissue Sarcoma: VEGFR-3 Is an Independent Predictor of Poor Prognosis
por: Kilvaer, Thomas K., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_afdfm694ibi27iv8o1eddskbsp